Essex Financial Services’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-667	Closed	-$354	–	287
2013 Q3	$354	Sell	667 -333	-33%	-$177	0.11%	166
2013 Q2	$234K	Buy	+1,000	New	+$234K	0.08%	221